TY - JOUR
T1 - Pre- and postsynaptic inhibition mediated by GABAB receptors in rat ventrolateral periaqueductal gray neurons
AU - Yang, Kun
AU - Furue, Hidemasa
AU - Kumamoto, Eiichi
AU - Dong, Yuan Xiang
AU - Yoshimura, Megumu
PY - 2003/1/10
Y1 - 2003/1/10
N2 - The present study examined the actions of a GABAB-receptor agonist, baclofen, on synaptic transmission in rat ventrolateral periaqueductal gray (PAG) neurons of brainstem slices by using whole-cell voltage-clamp recordings. Baclofen (10μM) induced a slow outward current (peak amplitude: 30.1±3.1pA, n=13) at -70mV, which persisted in the presence of tetrodotoxin (0.5μM) and was diminished in the presence of postsynaptic intracellular K+-channel blockers (Cs+ and TEA) and GDP-β-S, indicating a direct postsynaptic depression mediated by K+ channels and G proteins. Baclofen (10μM) also decreased the frequency of both glutamatergic spontaneous EPSC (by 36±7%, n=11) and GABAergic spontaneous IPSC (by 37±12%, n=6) without changes in their amplitudes, indicating its presynaptic inhibitions. Taken together, the activation of postsynaptic GABAB receptors inhibits ventrolateral PAG neurons directly. At the same time, activating presynaptic GABAB receptors on glutamatergic and GABAergic nerve terminals inhibits glutamate and GABA release, respectively. The overall effects might influence an output of ventrolateral PAG neurons that build up the descending pain control system to the spinal dorsal horn.
AB - The present study examined the actions of a GABAB-receptor agonist, baclofen, on synaptic transmission in rat ventrolateral periaqueductal gray (PAG) neurons of brainstem slices by using whole-cell voltage-clamp recordings. Baclofen (10μM) induced a slow outward current (peak amplitude: 30.1±3.1pA, n=13) at -70mV, which persisted in the presence of tetrodotoxin (0.5μM) and was diminished in the presence of postsynaptic intracellular K+-channel blockers (Cs+ and TEA) and GDP-β-S, indicating a direct postsynaptic depression mediated by K+ channels and G proteins. Baclofen (10μM) also decreased the frequency of both glutamatergic spontaneous EPSC (by 36±7%, n=11) and GABAergic spontaneous IPSC (by 37±12%, n=6) without changes in their amplitudes, indicating its presynaptic inhibitions. Taken together, the activation of postsynaptic GABAB receptors inhibits ventrolateral PAG neurons directly. At the same time, activating presynaptic GABAB receptors on glutamatergic and GABAergic nerve terminals inhibits glutamate and GABA release, respectively. The overall effects might influence an output of ventrolateral PAG neurons that build up the descending pain control system to the spinal dorsal horn.
KW - Baclofen
KW - GABA receptor
KW - Periaqueductal gray
KW - Rat
UR - https://www.scopus.com/pages/publications/0037428262
U2 - 10.1016/S0006-291X(03)00156-6
DO - 10.1016/S0006-291X(03)00156-6
M3 - 文章
C2 - 12604336
AN - SCOPUS:0037428262
SN - 0006-291X
VL - 302
SP - 233
EP - 237
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 2
ER -